Literature DB >> 21964647

Does the risk of stomach cancer remain among second-generation immigrants in Sweden?

Seyed Mohsen Mousavi1, Kristina Sundquist, Kari Hemminki.   

Abstract

The observed increased risks of noncardia stomach cancer among foreign-born second-generation immigrants compared to the Swedes suggest that these immigrants were infected by Helicobacter pylori before immigration.

Entities:  

Mesh：

Year:  2011        PMID： 21964647     DOI： 10.1007/s10120-011-0096-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


  24 in total

1.  Risk of transitional-cell carcinoma of the bladder in first- and second-generation immigrants to Sweden.

Authors:  Seyed Mohsen Mousavi; Jan Sundquist; Kari Hemminki
Journal:  Eur J Cancer Prev       Date:  2010-07       Impact factor: 2.497

2.  Cancer risks in Nordic immigrants and their offspring in Sweden.

Authors:  K Hemminki; X Li
Journal:  Eur J Cancer       Date:  2002-12       Impact factor: 9.162

3.  On cancer risks in second-generation immigrants to Sweden.

Authors:  Andrés Bendesky; Patricia Ostrosky-Wegman
Journal:  Int J Cancer       Date:  2002-09-20       Impact factor: 7.396

4.  Helicobacter pylori infection in different generations of Hispanics in the San Francisco Bay Area.

Authors:  Chiaojung J Tsai; Sharon Perry; Luz Sanchez; Julie Parsonnet
Journal:  Am J Epidemiol       Date:  2005-07-13       Impact factor: 4.897

Review 5.  Concepts in the prevention of adenocarcinoma of the distal esophagus and proximal stomach.

Authors:  Rhonda F Souza; Stuart J Spechler
Journal:  CA Cancer J Clin       Date:  2005 Nov-Dec       Impact factor: 508.702

Review 6.  Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.

Authors: 
Journal:  Gut       Date:  2001-09       Impact factor: 23.059

7.  Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status.

Authors:  Svein Hansen; Stein Emil Vollset; Mohammad H Derakhshan; Valerie Fyfe; Kjetil K Melby; Steinar Aase; Egil Jellum; Kenneth E L McColl
Journal:  Gut       Date:  2007-02-22       Impact factor: 23.059

8.  The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies.

Authors:  Kari Hemminki; Jianguang Ji; Andreas Brandt; Seyed Mohsen Mousavi; Jan Sundquist
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

9.  Impact of migration on Helicobacter pylori seroprevalence in the offspring of Turkish immigrants in Germany.

Authors:  Mustafa Porsch-Ozcürümez; Wilhelm Doppl; Philip Daniel Hardt; Henning Schnell-Kretschmer; Mehmet Tuncay; Ahmet Akinci; Yaşar Bilgin; Hans-Ulrich Klör
Journal:  Turk J Pediatr       Date:  2003 Jul-Sep       Impact factor: 0.552

Review 10.  Gastric cancer.

Authors:  Paul Lochhead; Emad M El-Omar
Journal:  Br Med Bull       Date:  2008-02-10       Impact factor: 4.291
View more
  3 in total

1.  Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city.

Authors:  Wouter J den Hollander; I Lisanne Holster; Caroline M den Hoed; Frances van Deurzen; Anneke J van Vuuren; Vincent W Jaddoe; Albert Hofman; Guillermo I Perez Perez; Martin J Blaser; Henriëtte A Moll; Ernst J Kuipers
Journal:  J Gastroenterol Hepatol       Date:  2013-11       Impact factor: 4.029

2.  Increased Incidence and Mortality of Gastric Cancer in Immigrant Populations from High to Low Regions of Incidence: A Systematic Review and Meta-Analysis.

Authors:  Baldeep S Pabla; Shailja C Shah; Juan E Corral; Douglas R Morgan
Journal:  Clin Gastroenterol Hepatol       Date:  2019-05-30       Impact factor: 11.382

3.  Importance of tumor location and histology in familial risk of upper gastrointestinal cancers: a nationwide cohort study.

Authors:  Elham Kharazmi; Masoud Babaei; Mahdi Fallah; Tianhui Chen; Kristina Sundquist; Kari Hemminki
Journal:  Clin Epidemiol       Date:  2018-09-04       Impact factor: 4.790
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.